SCHEMBL6567981

SCHEMBL6567981

CCC(=O)c1cc(NC(=O)Nc2ccc(OC)c(OC)c2)ccc1OCc1ccccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.53
KMT2A Q03164 6/20 0.51
MEN1 O00255 5/20 0.51
LMNA P02545 2/20 0.51
MAPT P10636 5/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
PTGS2 P35354 1/20 0.48
TP53 P04637 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
ALDH1A1 P00352 2/20 0.46
S1PR1 P21453 2/20 0.46
S1PR4 O95977 1/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
GPR35 Q9HC97 1/20 0.46
NPC1 O15118 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566584 0.89 PTGER3 (0.52) HDAC8KMT2AMEN1LMNAMAPT
SCHEMBL6567010 0.82 RAB9A (0.50) KMT2AMEN1LMNAMAPTTP53
SCHEMBL6567986 0.82 SMPD1 (0.53) KMT2AMEN1LMNAMAPTRAB9A
SCHEMBL6566712 0.81 MEN1 (0.65) HDAC8KMT2AMEN1LMNAMAPT
SCHEMBL6567936 0.81 MAPT (0.54) KMT2AMEN1LMNAMAPTTP53
SCHEMBL6566825 0.80 MEN1 (0.51) KMT2AMEN1LMNAMAPTHDAC1
SCHEMBL6566666 0.80 MEN1 (0.47) KMT2AMEN1LMNAMAPTTP53
SCHEMBL6565954 0.79 MEN1 (0.56) KMT2AMEN1LMNAMAPTTP53
SCHEMBL6566581 0.78 SMN1; SMN2 (0.57) KMT2AMEN1LMNAMAPTTP53
SCHEMBL6566760 0.78 NR1H4 (0.50) KMT2AMEN1LMNAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 HDAC8 701/4885KMT2A 3137/4885MEN1 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.